Cargando…
Protein Aggregation and Protein Instability Govern Familial Amyotrophic Lateral Sclerosis Patient Survival
The nature of the “toxic gain of function” that results from amyotrophic lateral sclerosis (ALS)-, Parkinson-, and Alzheimer-related mutations is a matter of debate. As a result no adequate model of any neurodegenerative disease etiology exists. We demonstrate that two synergistic properties, namely...
Autores principales: | Wang, Qi, Johnson, Joshua L, Agar, Nathalie Y.R, Agar, Jeffrey N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2486295/ https://www.ncbi.nlm.nih.gov/pubmed/18666828 http://dx.doi.org/10.1371/journal.pbio.0060170 |
Ejemplares similares
-
Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013) -
Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis
por: Malik, Ravinder, et al.
Publicado: (2020) -
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Duranti, Elisa, et al.
Publicado: (2022) -
Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?
por: Lee, Shynrye, et al.
Publicado: (2015) -
Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
por: McAlary, Luke, et al.
Publicado: (2019)